TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36232040

Group type: EXPERIMENTAL
Intervention: Cognitively challenging physical activity intervention
Number of subjects: 99

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 99
Study: 32236916

Group type: EXPERIMENTAL
Intervention: Alternative distinct naming strategy
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard distinct naming strategy
Number of subjects: 25
Study: 36121160

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 14

Group type: COMPARATOR
Intervention: Prone position
Number of subjects: 14
Study: 35177807

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (60% carbohydrate as a proportion of total energy, n = 10)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Moderate-carbohydrate diet (40%, n = 8)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Low-carbohydrate diet (20%, n = 9)
Number of subjects: 27
Study: 35340239

Group type: EXPERIMENTAL
Intervention: Systematic dietary education combined with multidisciplinary nursing
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional intervention (routine group)
Number of subjects: 90
Study: 34984483

Group type: EXPERIMENTAL
Intervention: Taperloc Complete full profile (TCFP)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Taperloc Complete reduced distal (TCRD)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Taperloc full profile (TFP)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Taperloc reduced distal (TRD)
Number of subjects: 100
Study: 34100952

Group type: EXPERIMENTAL
Intervention: Visual representation of patients' past culture data
Number of subjects: 273

Group type: COMPARATOR
Intervention: Standard EHR functionality (control)
Number of subjects: 273
Study: 35319001

Group type: EXPERIMENTAL
Intervention: Strength endurance training
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Power training
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Absolute strength training
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Relative strength training
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Detraining after resistance training
Number of subjects: 95
Study: 32202507

Group type: EXPERIMENTAL
Intervention: E-learning group (EG)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 35856287

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) plus standard of care (SOC)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 19
Study: 33649872

Group type: COMPARATOR
Intervention: 0% PKC inclusion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 8% PKC inclusion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 16% PKC inclusion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 24% PKC inclusion
Number of subjects: 40
Study: 36443712

Group type: EXPERIMENTAL
Intervention: Dialectical Behavioral Therapy-based group treatment (DBT-bGT)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: DBT-bGT
Number of subjects: 121
Study: 33930527

Group type: EXPERIMENTAL
Intervention: New treatment (hazard ratio equals 0.7)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable (null hypothesis: hazard ratio equals 1)
Number of subjects: 0
Study: 32525761

Group type: EXPERIMENTAL
Intervention: Dynamic elastomeric fabric orthoses (compression shorts) with standard postnatal care
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard postnatal care alone (comparison group)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 51
Study: 35470717

Group type: EXPERIMENTAL
Intervention: Ultrasound guided distal radial artery cannulation (group D)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ultrasound guided conventional radial artery cannulation (group W)
Number of subjects: 200
Study: 34975830

Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (500 mg daily for 14 days)
Number of subjects: 120
Study: 33539242

Group type: EXPERIMENTAL
Intervention: Individual teaching intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 200
Study: 35796695

Group type: EXPERIMENTAL
Intervention: Eriomin (200 mg/d for 12 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 34155073

Group type: EXPERIMENTAL
Intervention: Usual care plus the GRRAND intervention (individualised rehabilitation programme)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 60
Study: 35367955

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy with a Well‐Being focus
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Mindfulness Based Cognitive Therapy
Number of subjects: 85
Study: 34310552

Group type: EXPERIMENTAL
Intervention: Lateral skull base approach for resection of vestibular schwannoma and postoperative monitoring
Number of subjects: 200
Study: 32691193

Group type: EXPERIMENTAL
Intervention: Day 7 blastocyst (SVBT) with diameter 180 μm
Number of subjects: 1143

Group type: EXPERIMENTAL
Intervention: Day 7 blastocyst (SVBT) with diameter 190 μm
Number of subjects: 1143

Group type: EXPERIMENTAL
Intervention: Day 7 blastocyst (SVBT) with diameter 200 μm
Number of subjects: 1143

Group type: EXPERIMENTAL
Intervention: Day 7 blastocyst (SVBT) with diameter 210 μm
Number of subjects: 1143

Group type: EXPERIMENTAL
Intervention: Day 7 blastocyst (SVBT) with diameter over 220 μm
Number of subjects: 1143

Group type: EXPERIMENTAL
Intervention: Day 7 blastocyst (SVBT) hatched
Number of subjects: 1143

Group type: COMPARATOR
Intervention: Day 2 single-embryo transfer (SET)
Number of subjects: 1143
Study: 35874984

Group type: EXPERIMENTAL
Intervention: Climate change affected scenario (CCA)
Number of subjects: 311

Group type: COMPARATOR
Intervention: Climate change unaffected scenario (CCU)
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Higher affective valence
Number of subjects: 311
Study: 34621327

Group type: EXPERIMENTAL
Intervention: Mifepristone combined with misoprostol
Number of subjects: 95

Group type: COMPARATOR
Intervention: Diethylstilbestrol combined with oxytocin
Number of subjects: 95
Study: 35861792

Group type: EXPERIMENTAL
Intervention: CBD 150 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CBD 300 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CBD 600 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 33727998

Group type: EXPERIMENTAL
Intervention: Intraoperative chemical splanchnicectomy of celiac ganglions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34838891

Group type: EXPERIMENTAL
Intervention: RT quality assurance (RTQA) practices mandated in trial protocol
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Institutional credentialing
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Protocol deviation outcomes published
Number of subjects: 42

Group type: COMPARATOR
Intervention: Advanced radiation techniques (IMRT, VMAT, SRS, SBRT)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Reporting protocol deviation outcomes
Number of subjects: 42
Study: 32711663

Group type: EXPERIMENTAL
Intervention: Multimedia exposure procedure
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 36

Group type: COMPARATOR
Intervention: Waiting List Group
Number of subjects: 36
Study: 33629525

Group type: EXPERIMENTAL
Intervention: Trabeculectomy (TE)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Baerveldt implant (BGI)
Number of subjects: 70
Study: 34165523

Group type: EXPERIMENTAL
Intervention: Reduced-intensity chemotherapy with oxaliplatin and capecitabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34464489

Group type: EXPERIMENTAL
Intervention: Locally applied vaginal estrogen cream
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 120
Study: 32375334

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (70 µg)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 35696838

Group type: EXPERIMENTAL
Intervention: Integrated Exposure Therapy (I‐PE)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Integrated Coping Skills Therapy (I‐CS)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Full Sample
Number of subjects: 119
Study: 32487113

Group type: EXPERIMENTAL
Intervention: Proton beam therapy (PBT)
Number of subjects: 0
Study: 33486855

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg administered immediately after surgery
Number of subjects: 38

Group type: COMPARATOR
Intervention: Ibuprofen 400 mg administered 30 min before surgery
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Postoperative analgesic treatment group
Number of subjects: 38

Group type: COMPARATOR
Intervention: Preoperative analgesic treatment group
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study: 32144336

Group type: EXPERIMENTAL
Intervention: SAP P11-4 and twice fluoride varnish
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: SAP P11-4 and twice weekly SAPM (home-application)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Fluoride varnish
Number of subjects: 90
Study: 36214818

Group type: EXPERIMENTAL
Intervention: Modified mid-urethral sling technique (mMUS)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Transobturator tape (TOT)
Number of subjects: 126
Study: 33689786

Group type: EXPERIMENTAL
Intervention: Estetrol 15 mg/drospirenone 3 mg (E4/DRSP)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Ethinylestradiol 20 µg/drospirenone 3 mg (EE/DRSP)
Number of subjects: 82
Study: 36328998

Group type: EXPERIMENTAL
Intervention: Engagement module
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Relaxation module
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Cognitive reframing module
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Activity selection module
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Parent psychoeducation module
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Seven other modules
Number of subjects: 3
Study: 36076498

Group type: EXPERIMENTAL
Intervention: Puerarin supplementation (90.2 mg daily)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study: 33975075

Group type: EXPERIMENTAL
Intervention: Mothers' voice
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: White noise
Number of subjects: 103

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 103
Study: 33559524

Group type: EXPERIMENTAL
Intervention: VX-210 (9 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33415874

Group type: EXPERIMENTAL
Intervention: Jin's three-needle combined with MyoTrac biostimulation therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: simple Jin's three-needle therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: simple MyoTrac biostimulation therapy
Number of subjects: 120
Study: 32097391

Group type: EXPERIMENTAL
Intervention: Polyethylene Glycol (PEG) 1gr/kg
Number of subjects: 51

Group type: COMPARATOR
Intervention: Lactulose 1cc/kg
Number of subjects: 51
Study: 37449542

Group type: EXPERIMENTAL
Intervention: Early local radiotherapy (LRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upfront local radiotherapy (LRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radical LRT including primary tumor surgery followed by radiotherapy (RT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LRT
Number of subjects: 0
Study: 34052395

Group type: EXPERIMENTAL
Intervention: Integrated Advanced Modular Manikin (AMM)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Peripheral simulators
Number of subjects: 42
Study: 32677458

Group type: EXPERIMENTAL
Intervention: Educational intervention on heart failure self-care resources and symptom management during index admission
Number of subjects: 218

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 218
Study: 34936606

Group type: EXPERIMENTAL
Intervention: Exercise (1 week after surgery)
Number of subjects: 225
Study: 34032997

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 antibodies detection using FDA approved ROCHE kit
Number of subjects: 15390

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 15390

Group type: EXPERIMENTAL
Intervention: Younger group (≤ 20 years)
Number of subjects: 15390
Study: 33032071

Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 20
Study: 34504990

Group type: EXPERIMENTAL
Intervention: Endocrine therapy plus ribociclib
Number of subjects: 565

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 565
Study: 35691448

Group type: EXPERIMENTAL
Intervention: Local consolidative therapy (LCT) plus standard-of-care systemic therapy or observation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Local consolidative therapy (LCT)
Number of subjects: 50
Study: 33773533

Group type: EXPERIMENTAL
Intervention: Combination therapy (counselling, intra oral camera assessment, and carbon monoxide monitoring)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbon monoxide monitoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Counselling and intra oral camera assessment
Number of subjects: 0

Group type: COMPARATOR
Intervention: General counselling only
Number of subjects: 0
Study: 36133438

Group type: EXPERIMENTAL
Intervention: Periocline-assisted periodontal basic therapy
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (periodontal basic therapy without periocline)
Number of subjects: 108
Study: 33994199

Group type: EXPERIMENTAL
Intervention: Sleep duration
Number of subjects: 116787

Group type: EXPERIMENTAL
Intervention: Insomnia complaints
Number of subjects: 116787

Group type: EXPERIMENTAL
Intervention: Ease of getting up in the morning
Number of subjects: 116787
Study: 34147963

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Routine clinical care
Number of subjects: 122
Study: 33060258

Group type: EXPERIMENTAL
Intervention: Aerosolized calfactant (Infasurf), 6 mL/kg (210 mg phospholipid/kg body weight), up to 3 treatments, at least 4 hours apart.
Number of subjects: 457

Group type: COMPARATOR
Intervention: Usual care (control group), determined by providers.
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Aerosolized calfactant (Infasurf)
Number of subjects: 457
Study: 35687033

Group type: EXPERIMENTAL
Intervention: Interruptions with 1‐min light half‐squat exercises every 20 min (EX)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Uninterrupted sitting (CON)
Number of subjects: 20
Study: 34347705

Group type: EXPERIMENTAL
Intervention: Ultrashort echo time (UTE) T2? cartilage mapping
Number of subjects: 10
Study: 33401223

Group type: COMPARATOR
Intervention: Aspirin (AP)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Salvianolate (SV)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combination (A + S)
Number of subjects: 18
Study: 33692185

Group type: EXPERIMENTAL
Intervention: PermaSeal (Ultradent)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Low-level laser (LLL, AsGaAl) at a wavelength of 780 nm (Laser XT Therapy, DMC, São Carlos, Brazil)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Both LLL and PermaSeal (Ultradent)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo (Control group)
Number of subjects: 140
Study: 32213141

Group type: EXPERIMENTAL
Intervention: Viscous fibre from konjac-based blend (KBB)
Number of subjects: 0
Study: 36881399

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 3526

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3526
Study: 34002374

Group type: EXPERIMENTAL
Intervention: Genetic generalized epilepsy (GGE)
Number of subjects: 12803

Group type: EXPERIMENTAL
Intervention: Higher beta and theta polygenic risk scores
Number of subjects: 12803

Group type: EXPERIMENTAL
Intervention: GGE genetic liability
Number of subjects: 12803
Study: 32979072

Group type: EXPERIMENTAL
Intervention: SGRQ
Number of subjects: 138
Study: 35387739

Group type: EXPERIMENTAL
Intervention: Single-dose antibiotic prophylaxis (2 g amoxicillin 1 h before surgery)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Single-dose prophylactic antibiotic (2 g amoxicillin 1 h before surgery) with additional doses after surgery (500 mg amoxicillin, q8h for 5 days)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Post-surgical antibiotics alone (500 mg amoxicillin, q8h for 5 days)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 450
Study: 33858400

Group type: EXPERIMENTAL
Intervention: Supportive home care program
Number of subjects: 116

Group type: COMPARATOR
Intervention: Routine hospital education program
Number of subjects: 116

Group type: COMPARATOR
Intervention: Supportive home care program vs Routine hospital education program
Number of subjects: 116
Study: 34068848

Group type: EXPERIMENTAL
Intervention: MCAT plus Collagen Matrix (CM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: MCAT plus Subepithelial Connective Tissue Graft (SCTG)
Number of subjects: 20
Study: 35762280

Group type: EXPERIMENTAL
Intervention: Psychosocial aftercare (PAC)
Number of subjects: 419

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 419
Study: 33767791

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg body weight)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Nesdonal (3-5 mg/kg body weight)
Number of subjects: 134
Study: 616118926

Group type: EXPERIMENTAL
Intervention: 20 mm diameter implant
Number of subjects: 32
Study: 35098466

Group type: EXPERIMENTAL
Intervention: 15 mg Cd/kg of feed
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 30 mg Cd/kg of feed
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 60 mg Cd/kg of feed
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (basal diet without additional Cd)
Number of subjects: 72
Study: 35555782

Group type: EXPERIMENTAL
Intervention: Vitamin D and calcium supplementation (2000 IU/d vitamin D3 and 1500 mg/d calcium)
Number of subjects: 2109

Group type: COMPARATOR
Intervention: Placebo (no vitamin D and calcium supplementation)
Number of subjects: 2109
Study: 35749758

Group type: EXPERIMENTAL
Intervention: LEM 10 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: LEM 20 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: LEM 30 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Zolpidem (ZOL) 30 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Suvoxexant (SUV) 40 mg
Number of subjects: 32
Study: 32967921

Group type: EXPERIMENTAL
Intervention: Metformin (DM+MF)
Number of subjects: 123

Group type: COMPARATOR
Intervention: DM-noMF (Control)
Number of subjects: 123
Study: 35822924

Group type: EXPERIMENTAL
Intervention: Mepolizumab 100 mg subcutaneously every 4 weeks for 52 weeks
Number of subjects: 407

Group type: COMPARATOR
Intervention: Placebo plus standard of care
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Mepolizumab 100 mg subcutaneously
Number of subjects: 407
Study: 34455849

Group type: EXPERIMENTAL
Intervention: Abbreviated antiplatelet therapy (APT) for 5 months in patients with OAC indication; 11 months in patients without OAC indication.
Number of subjects: 4579

Group type: EXPERIMENTAL
Intervention: Abbreviated APT for patients without OAC indication.
Number of subjects: 4579

Group type: COMPARATOR
Intervention: Nonabbreviated APT for patients with OAC indication; ≥2 months dual APT followed by single APT.
Number of subjects: 4579

Group type: COMPARATOR
Intervention: Nonabbreviated APT for patients without OAC indication; ≥5 months dual APT followed by single APT.
Number of subjects: 4579
Study: 33059457

Group type: EXPERIMENTAL
Intervention: WASH interventions
Number of subjects: 640

Group type: COMPARATOR
Intervention: Non-WASH schools
Number of subjects: 640
Study: 36002048

Group type: EXPERIMENTAL
Intervention: Intramuscular injection of NL003
Number of subjects: 540

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study: 33521871

Group type: EXPERIMENTAL
Intervention: BMI ≥ 40 group
Number of subjects: 2282

Group type: COMPARATOR
Intervention: BMI < 40 group
Number of subjects: 2282
Study: 32917601

Group type: EXPERIMENTAL
Intervention: Political advertisements
Number of subjects: 34000
Study: 34618907

Group type: EXPERIMENTAL
Intervention: CBT‐I + Light
Number of subjects: 101

Group type: COMPARATOR
Intervention: TAU+
Number of subjects: 101
Study: 32097932

Group type: EXPERIMENTAL
Intervention: Drug-Eluting Stent (DES)
Number of subjects: 8782

Group type: COMPARATOR
Intervention: Bare-Metal Stent (BMS)
Number of subjects: 8782
Study: 35507141

Group type: EXPERIMENTAL
Intervention: Normal saline
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Normal saline plus oral acetazolamide (5 mg/kg/day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Half saline plus 75 mEq/L sodium bicarbonate
Number of subjects: 120
Study: 34193503

Group type: EXPERIMENTAL
Intervention: Daily PEP flute usage as add-on to usual care
Number of subjects: 400

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 400
Study: 32875927

Group type: EXPERIMENTAL
Intervention: Past sodium intake (tertile 3)
Number of subjects: 1191

Group type: EXPERIMENTAL
Intervention: Contemporary sodium intake (tertile 3)
Number of subjects: 1191
Study: 35713760

Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 281

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 281
Study: 33407760

Group type: EXPERIMENTAL
Intervention: Regression approach for personalised treatment recommendation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modification of Kraemer’s approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regression method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Kraemer’s approach
Number of subjects: 0
Study: 33753890

Group type: EXPERIMENTAL
Intervention: HE&PA combined
Number of subjects: 0
Study: 32914421

Group type: EXPERIMENTAL
Intervention: Dynamic navigation system
Number of subjects: 6

Group type: COMPARATOR
Intervention: Traditional freehand protocol
Number of subjects: 6
Study: 32244495

Group type: EXPERIMENTAL
Intervention: Arrowhead Business Group (ABG) entrepreneurship education program
Number of subjects: 394

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 394